Non-invasive cholesterol reader market seen reaching $2.63 billion by 2030

The market for non-invasive cholesterol readers is projected to rise from $1.3 billion in 2025 to $2.63 billion by 2030, driven by cardiovascular disease prevalence, healthcare spending and demand for painless testing. North America led in 2025, while Asia-Pacific is forecast to grow fastest.

Why it matters: - Non-invasive cholesterol readers could make cholesterol monitoring easier for patients and clinicians by removing blood draws and needles. - The market is growing as cardiovascular disease rates rise and healthcare systems look for faster, lower-friction diagnostic tools. - Demand is also tied to home healthcare, telemedicine and wearable monitoring, which can expand access beyond traditional clinics.

What happened: - The Business Research Company published its Non-Invasive Cholesterol Reader Global Market Report 2026 – Market Size, Trends, And Forecast 2026-2035. - The report says the market is projected to grow from $1.3 billion in 2025 to $1.5 billion in 2026. - The report forecasts the market will reach $2.63 billion by 2030. - The report was released Aug. 19, 2026. - A free sample is available here. - The full report is available here.

The details: - The 2026 market size forecast implies 15.4% growth from 2025 to 2026. - The report projects a 15.1% CAGR from 2026 to 2030. - The report links historical growth to cardiovascular disease prevalence, higher awareness of cholesterol monitoring, demand for non-invasive diagnostics, home healthcare adoption and advances in optical sensor technology. - Future growth drivers include AI-driven diagnostics, telemedicine integration, device miniaturization, expansion in emerging regions and continuous real-time monitoring. - Key trends identified in the forecast period include optical sensor-based monitoring devices, wearable cholesterol trackers, portable diagnostics, mobile health app connectivity and home-based cholesterol testing kits. - The technology uses optical sensors, spectroscopy or electromagnetic waves to detect cholesterol through the skin or other external methods. - The devices are designed for painless, quick and user-friendly cholesterol testing in clinical and home settings. - The CDC reported cardiovascular diseases caused 919,032 deaths in the US in 2023, which was about one-third of all deaths. - The UK Office for National Statistics reported government-funded healthcare spending reached $346 billion (£258 billion) in 2024, up 2.5% in real terms from 2023. - North America held the largest market share in 2025. - Asia-Pacific is expected to be the fastest-growing region during the forecast period. - The report also covers South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa. - The 2026 edition adds market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technology and future trend analysis, plus updated graphics and tables.

Between the lines: - The report points to a market shifting from niche diagnostics toward broader consumer and remote-care use. - AI, telemedicine and mobile connectivity suggest cholesterol monitoring is being positioned as part of a more continuous care model. - Regional leadership in North America and faster growth in Asia-Pacific indicate both mature demand and expanding adoption are shaping the market at the same time.

What's next: - The market’s near-term trajectory will hinge on whether non-invasive devices can prove accurate, affordable and easy to integrate into routine care. - Growth will likely depend on broader adoption in home health, mobile health platforms and emerging markets. - The Business Research Company says the updated report is designed to support market sizing, forecasting and competitive analysis.

The bottom line: - Non-invasive cholesterol readers are moving from emerging diagnostic tools toward a faster-growing global market tied to cardiovascular prevention and remote monitoring.